| 3.45 0.23 (7.14%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.29 |
1-year : | 5.02 |
| Resists | First : | 3.68 |
Second : | 4.29 |
| Pivot price | 3.29 |
|||
| Supports | First : | 3.27 |
Second : | 3.03 |
| MAs | MA(5) : | 3.31 | MA(20) : | 3.25 |
| MA(100) : | 4.08  |
MA(250) : | 5.3 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 37.6 |
D(3) : | 35.6 |
| RSI | RSI(14): 55.7 |
|||
| 52-week | High : | 9.32 | Low : | 3.02 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SRTS ] has closed below upper band by 22.0%. Bollinger Bands are 46.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 33 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.51 - 3.52 | 3.52 - 3.54 |
| Low: | 3.23 - 3.25 | 3.25 - 3.27 |
| Close: | 3.42 - 3.45 | 3.45 - 3.48 |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Thu, 09 Oct 2025
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, - GlobeNewswire
Wed, 08 Oct 2025
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Sat, 04 Oct 2025
Insufficient Growth At Sensus Healthcare, Inc. (NASDAQ:SRTS) Hampers Share Price - simplywall.st
Mon, 29 Sep 2025
Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing - Nasdaq
Sun, 28 Sep 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS - PR Newswire
Tue, 23 Sep 2025
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know - sharewise.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 16.9 (%) |
| Held by Institutions | 29.5 (%) |
| Shares Short | 752 (K) |
| Shares Short P.Month | 826 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.57 |
| Profit Margin | -2.3 % |
| Operating Margin | 40.8 % |
| Return on Assets (ttm) | -1.5 % |
| Return on Equity (ttm) | -1.7 % |
| Qtrly Rev. Growth | 155.6 % |
| Gross Profit (p.s.) | 1.19 |
| Sales Per Share | 2.28 |
| EBITDA (p.s.) | -0.07 |
| Qtrly Earnings Growth | 433.2 % |
| Operating Cash Flow | 4 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | -69 |
| PEG Ratio | 0 |
| Price to Book value | 2.19 |
| Price to Sales | 1.51 |
| Price to Cash Flow | 15.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|